Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

August 1, 2021; Volume 62,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Tade, Funmilayo I.

    1. Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on <sup>18</sup>F-Fluciclovine PET/CT Guidance
      You have access
      Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
      Olayinka A. Abiodun-Ojo, Ashesh B. Jani, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Oluwaseun A. Odewole, Funmilayo I. Tade, Shreyas S. Joshi, Viraj A. Master, Bridget Fielder, Raghuveer K. Halkar, Chao Zhang, Subir Goyal, Mark M. Goodman and David M. Schuster
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1089-1096; DOI: https://doi.org/10.2967/jnumed.120.256784
  2. Taran, Florin-Andrei

    1. Lymph Node Staging with a Combined Protocol of <sup>18</sup>F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma
      You have access
      Lymph Node Staging with a Combined Protocol of 18F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma
      Matthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, Stefan Kommoss, Konstantin Nikolaou, Samine Sahbai, Christian la Fougère, Sara Yvonne Brucker and Helmut Dittmann
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1062-1067; DOI: https://doi.org/10.2967/jnumed.120.255919
  3. Tiraboschi, Pietro

    1. Open Access
      Postinfectious Neurologic Complications in COVID-19: A Complex Case Report
      Pietro Tiraboschi, Rubjona Xhani, Simone M. Zerbi, Angelo Corso, Isabella Martinelli, Laura Fusi, Giampiero Grampa, Andrea Lombardo, Paola Cavalcante, Cristina Cappelletti, Francesca Andreetta, Alberto Sironi, Alberto Redolfi and Cristina Muscio
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1171-1176; DOI: https://doi.org/10.2967/jnumed.120.256099
  4. Tournier, Nicolas

    1. You have access
      Repurposing 99mTc-Mebrofenin as a Probe for Molecular Imaging of Hepatocyte Transporters
      Solène Marie, Irene Hernández-Lozano, Oliver Langer and Nicolas Tournier
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1043-1047; DOI: https://doi.org/10.2967/jnumed.120.261321
  5. Urban, Szabolcs

    1. Radiation Dosimetry of <sup>99m</sup>Tc-PSMA I&amp;S: A Single-Center Prospective Study
      You have access
      Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study
      Szabolcs Urbán, Catherine Meyer, Magnus Dahlbom, István Farkas, Gábor Sipka, Zsuzsanna Besenyi, Johannes Czernin, Jeremie Calais and László Pávics
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1075-1081; DOI: https://doi.org/10.2967/jnumed.120.253476
  6. Van Den Berg, Mariska P.M.

    1. Mapping Arginase Expression with <sup>18</sup>F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids
      You have access
      Mapping Arginase Expression with 18F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids
      Gonçalo S. Clemente, Inês F. Antunes, Santosh Kurhade, Mariska P.M. van den Berg, Jürgen W.A. Sijbesma, Aren van Waarde, Rogier C. Buijsman, Nicole Willemsen-Seegers, Reinoud Gosens, Herman Meurs, Alexander Dömling and Philip H. Elsinga
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1163-1170; DOI: https://doi.org/10.2967/jnumed.120.255968
  7. Vaneycken, Ilse

    1. Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
      You have access
      Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
      Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P. Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D. Windhorst, Frank van der Aa, N. Harry Hendrikse, Jos L.E. Eersels, Hendrik Everaert, Pieterjan Gykiere, Nick Devoogdt, Geert Raes, Tony Lahoutte and Marleen Keyaerts
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1097-1105; DOI: https://doi.org/10.2967/jnumed.120.255679
  8. Vanhoeij, Marian

    1. Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
      You have access
      Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
      Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P. Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D. Windhorst, Frank van der Aa, N. Harry Hendrikse, Jos L.E. Eersels, Hendrik Everaert, Pieterjan Gykiere, Nick Devoogdt, Geert Raes, Tony Lahoutte and Marleen Keyaerts
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1097-1105; DOI: https://doi.org/10.2967/jnumed.120.255679
  9. Van Waarde, Aren

    1. Synthesis and Evaluation of <sup>18</sup>F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-<sup>18</sup>F-Fluoro-5α-Dihydrotestosterone
      You have access
      Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-18F-Fluoro-5α-Dihydrotestosterone
      Inês F. Antunes, Rutger J. Dost, Hilde D. Hoving, Aren van Waarde, Rudi A.J.O Dierckx, Douwe F. Samplonius, Wijnand Helfrich, Philip H. Elsinga, Erik F.J. de Vries and Igle J. de Jong
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1140-1145; DOI: https://doi.org/10.2967/jnumed.120.253641
    2. Mapping Arginase Expression with <sup>18</sup>F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids
      You have access
      Mapping Arginase Expression with 18F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids
      Gonçalo S. Clemente, Inês F. Antunes, Santosh Kurhade, Mariska P.M. van den Berg, Jürgen W.A. Sijbesma, Aren van Waarde, Rogier C. Buijsman, Nicole Willemsen-Seegers, Reinoud Gosens, Herman Meurs, Alexander Dömling and Philip H. Elsinga
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1163-1170; DOI: https://doi.org/10.2967/jnumed.120.255968
  10. Vargas, Hebert Alberto

    1. Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with <sup>18</sup>F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
      You have access
      Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
      Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602
« Previous (Pages : 15 16 17 18 19 20 21 22 ... 22) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (8)
Journal of Nuclear Medicine
Vol. 62, Issue 8
August 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-18F-Fluoro-5α-Dihydrotestosterone
  • Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire